Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling.

Blasi F, Sidenius N.

FEBS Lett. 2010 May 3;584(9):1923-30. doi: 10.1016/j.febslet.2009.12.039. Epub 2009 Dec 27. Review.

2.

The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface.

Behrendt N, Rønne E, Danø K.

Biol Chem Hoppe Seyler. 1995 May;376(5):269-79. Review.

PMID:
7662169
3.
5.

Differential proteome expression associated with urokinase plasminogen activator receptor (uPAR) suppression in malignant epithelial cancer.

Saldanha RG, Xu N, Molloy MP, Veal DA, Baker MS.

J Proteome Res. 2008 Nov;7(11):4792-806. doi: 10.1021/pr800357h. Epub 2008 Sep 23.

PMID:
18808175
6.
7.

Pericellular proteolysis by leukocytes and tumor cells on substrates: focal activation and the role of urokinase-type plasminogen activator.

Kindzelskii AL, Amhad I, Keller D, Zhou MJ, Haugland RP, Garni-Wagner BA, Gyetko MR, Todd RF 3rd, Petty HR.

Histochem Cell Biol. 2004 Apr;121(4):299-310. Epub 2004 Mar 20.

8.

Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodies.

Rasch MG, Pass J, Illemann M, Høyer-Hansen G, Lund IK.

J Immunol Methods. 2008 Nov 30;339(1):55-65. doi: 10.1016/j.jim.2008.08.002. Epub 2008 Aug 30.

PMID:
18761343
9.

The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.

Hildenbrand R, Schaaf A.

Int J Oncol. 2009 Jan;34(1):15-23.

PMID:
19082473
10.

Regulation of urokinase receptor proteolytic function by the tetraspanin CD82.

Bass R, Werner F, Odintsova E, Sugiura T, Berditchevski F, Ellis V.

J Biol Chem. 2005 Apr 15;280(15):14811-8. Epub 2005 Jan 27.

11.
12.

Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth.

Ossowski L, Aguirre-Ghiso JA.

Curr Opin Cell Biol. 2000 Oct;12(5):613-20. Review.

PMID:
10978898
13.

Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.

Holst-Hansen C, Johannessen B, Høyer-Hansen G, Rømer J, Ellis V, Brünner N.

Clin Exp Metastasis. 1996 May;14(3):297-307.

PMID:
8674284
15.
17.
18.

Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction.

Tarui T, Mazar AP, Cines DB, Takada Y.

J Biol Chem. 2001 Feb 9;276(6):3983-90. Epub 2000 Oct 26.

19.

Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading.

Planus E, Barlovatz-Meimon G, Rogers RA, Bonavaud S, Ingber DE, Wang N.

J Cell Sci. 1997 May;110 ( Pt 9):1091-8.

20.

Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion.

Bonavaud S, Charrière-Bertrand C, Rey C, Leibovitch MP, Pedersen N, Frisdal E, Planus E, Blasi F, Gherardi R, Barlovatz-Meimon G.

J Cell Sci. 1997 May;110 ( Pt 9):1083-9.

Supplemental Content

Support Center